ArticleOncotarget2015

Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.

Rujiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.